BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31830850)

  • 1. An Introduction to Calculating Bayes Factors in JASP for Speech, Language, and Hearing Research.
    Brydges CR; Gaeta L
    J Speech Lang Hear Res; 2019 Dec; 62(12):4523-4533. PubMed ID: 31830850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Analysis of Nonsignificant Results in Audiology Using Bayes Factors.
    Brydges CR; Gaeta L
    J Speech Lang Hear Res; 2019 Dec; 62(12):4544-4553. PubMed ID: 31805244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian alternatives for common null-hypothesis significance tests in psychiatry: a non-technical guide using JASP.
    Quintana DS; Williams DR
    BMC Psychiatry; 2018 Jun; 18(1):178. PubMed ID: 29879931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian alternatives to null hypothesis significance testing in biomedical research: a non-technical introduction to Bayesian inference with JASP.
    Kelter R
    BMC Med Res Methodol; 2020 Jun; 20(1):142. PubMed ID: 32503439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian Analysis of Evidence in Support of the Null Hypothesis in Gerontological Psychology (or Lack Thereof).
    Brydges CR; Bielak AAM
    J Gerontol B Psychol Sci Soc Sci; 2020 Jan; 75(1):58-66. PubMed ID: 30877301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian inference of population prevalence.
    Ince RA; Paton AT; Kay JW; Schyns PG
    Elife; 2021 Oct; 10():. PubMed ID: 34612811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequentist, Bayesian Analysis and Complementary Statistical Tools for Geriatric and Rehabilitation Fields: Are Traditional Null-Hypothesis Significance Testing Methods Sufficient?
    Nascimento DDC; Rolnick N; da Silva Almeida I; Cipriano Junior G; Durigan JL
    Clin Interv Aging; 2024; 19():277-287. PubMed ID: 38380229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. fbst: An R package for the Full Bayesian Significance Test for testing a sharp null hypothesis against its alternative via the e value.
    Kelter R
    Behav Res Methods; 2022 Jun; 54(3):1114-1130. PubMed ID: 34471963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of issues about null hypothesis Bayesian testing.
    Tendeiro JN; Kiers HAL
    Psychol Methods; 2019 Dec; 24(6):774-795. PubMed ID: 31094544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian inference for psychology. Part II: Example applications with JASP.
    Wagenmakers EJ; Love J; Marsman M; Jamil T; Ly A; Verhagen J; Selker R; Gronau QF; Dropmann D; Boutin B; Meerhoff F; Knight P; Raj A; van Kesteren EJ; van Doorn J; Šmíra M; Epskamp S; Etz A; Matzke D; de Jong T; van den Bergh D; Sarafoglou A; Steingroever H; Derks K; Rouder JN; Morey RD
    Psychon Bull Rev; 2018 Feb; 25(1):58-76. PubMed ID: 28685272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Bayesian posterior significance and effect size indices for the two-sample t-test to support reproducible medical research.
    Kelter R
    BMC Med Res Methodol; 2020 Apr; 20(1):88. PubMed ID: 32321438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Things we still haven't learned (so far).
    Ivarsson A; Andersen MB; Stenling A; Johnson U; Lindwall M
    J Sport Exerc Psychol; 2015 Aug; 37(4):449-61. PubMed ID: 26442774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementing the P-value from null-hypothesis significance testing with a Bayes factor from null-hypothesis Bayesian testing.
    Malone HE; Coyne I
    Nurse Res; 2020 Nov; ():. PubMed ID: 33150776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayes factor design analysis: Planning for compelling evidence.
    Schönbrodt FD; Wagenmakers EJ
    Psychon Bull Rev; 2018 Feb; 25(1):128-142. PubMed ID: 28251595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian analysis for nurse and midwifery research: statistical, practical and ethical benefits.
    Malone HE; Coyne I
    Nurse Res; 2023 Jan; ():. PubMed ID: 36655468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Examination of Effect Sizes and Statistical Power in Speech, Language, and Hearing Research.
    Gaeta L; Brydges CR
    J Speech Lang Hear Res; 2020 May; 63(5):1572-1580. PubMed ID: 32343919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Speech-Language-Hearing Association. Classification of speech-language pathology and audiology procedures and communication disorders.
    ASHA; 1987 Dec; 29(12):49-53. PubMed ID: 3322299
    [No Abstract]   [Full Text] [Related]  

  • 18. A Bayesian analysis of non-significant rehabilitation findings: Evaluating the evidence in favour of truly absent treatment effects.
    Kinney AR; Middleton A; Graham JE
    Ann Phys Rehabil Med; 2021 Jul; 64(4):101425. PubMed ID: 32805456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting the results of clinical trials, embracing uncertainty: A Bayesian approach.
    Frost SA; Alexandrou E; Schulz L; Aneman A
    Acta Anaesthesiol Scand; 2021 Feb; 65(2):146-150. PubMed ID: 33051864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To P or Not to P: Backing Bayesian Statistics.
    Buchinsky FJ; Chadha NK
    Otolaryngol Head Neck Surg; 2017 Dec; 157(6):915-918. PubMed ID: 29192853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.